Shorted
Trajan Group Holdings logo
TRJ

Trajan Group Holdings

Pharmaceuticals, Biotechnology & Life Sciences

Trajan Group Holdings develops and manufactures analytical and life sciences instruments and devices. The company focuses on creating solutions for biological, environmental, and food-related measurements, aiming to improve personal health through scientific tools. Trajan partners in producing critical components and materials for analytical workflow and measurement.

Short position

short percentage0.00%
reported shorts1.4K
shares on issue152.864M

Trajan Group Holdings (ASX:TRJ) has 0.00% of its shares on issue reported as short positions as of 17 July 2026, or about 1,406 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. TRJ is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Trajan Group Holdings (TRJ) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
1d ago

Is Trajan Group Turning the Corner After Its Update (ASX:TRJ)?

Highlights Trajan reported a firmer initial quarter with cost savings flowing through. Net debt fell during the period while revenue edged higher. More specific guidance is due at the annual meeting later this month. Trajan Group (ASX:TRJ) opened the new financial year with a trading update that points to earnings momentum, as cost reductions and pricing actions start to show up in the numbers. The analytical-science supplier reported on a session when the Australian market finished a touch l...

Continue reading